Trial Outcomes & Findings for Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement (NCT NCT03506347)
NCT ID: NCT03506347
Last Updated: 2020-01-27
Results Overview
Mean vancomycin concentration in fat measured in ug/g at surgical closure
Recruitment status
COMPLETED
Study phase
PHASE2/PHASE3
Target enrollment
24 participants
Primary outcome timeframe
Approximately 60 minutes post surgical incision
Results posted on
2020-01-27
Participant Flow
Participant milestones
| Measure |
Vancomycin 15mg/kg IV
Will receive 15mg/kg based on actual body weight (maximum of 2g) of vancomycin via the systemic route at a rate of 15mg/kg as per hospital guidelines. Systemic IV vancomycin is given via a forearm vein, given over an infusion timed to finish immediately prior to surgery.
Vancomycin: Antibiotic
|
Vancomycin 500mg Intraosseous
Will have the limb exsanguinated and an above knee tourniquet inflated to 300 mmHg. Immediately following tourniquet inflation, Group B will receive 500mg of vancomycin, via an EZ-IO intraosseous cannula. The vancomycin would be administered in 150ml of saline solution. The intraosseous cannula would be placed into the epiphysis of the proximal tibia. The tourniquet will be left inflated for 10 minutes following completion of the intraosseous regional administration (IORA) injection then deflated.
Vancomycin: Antibiotic
|
|---|---|---|
|
Overall Study
STARTED
|
12
|
12
|
|
Overall Study
COMPLETED
|
12
|
12
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Race and Ethnicity were not collected from any participant.
Baseline characteristics by cohort
| Measure |
Vancomycin 15mg/kg IV
n=12 Participants
Will receive 15mg/kg based on actual body weight (maximum of 2g) of vancomycin via the systemic route at a rate of 15mg/kg as per hospital guidelines. Systemic IV vancomycin is given via a forearm vein, given over an infusion timed to finish immediately prior to surgery.
Vancomycin: Antibiotic
|
Vancomycin 500mg Intraosseous
n=12 Participants
Will have the limb exsanguinated and an above knee tourniquet inflated to 300 mmHg. Immediately following tourniquet inflation, Group B will receive 500mg of vancomycin, via an EZ-IO intraosseous cannula. The vancomycin would be administered in 150ml of saline solution. The intraosseous cannula would be placed into the epiphysis of the proximal tibia. The tourniquet will be left inflated for 10 minutes following completion of the IORA injection then deflated.
Vancomycin: Antibiotic
|
Total
n=24 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
68 years
STANDARD_DEVIATION 8.29 • n=12 Participants
|
69.1 years
STANDARD_DEVIATION 8.15 • n=12 Participants
|
68 years
STANDARD_DEVIATION 8.07 • n=24 Participants
|
|
Sex: Female, Male
Female
|
7 Participants
n=12 Participants
|
5 Participants
n=12 Participants
|
12 Participants
n=24 Participants
|
|
Sex: Female, Male
Male
|
5 Participants
n=12 Participants
|
7 Participants
n=12 Participants
|
12 Participants
n=24 Participants
|
|
Race and Ethnicity Not Collected
|
—
|
—
|
0 Participants
Race and Ethnicity were not collected from any participant.
|
|
Region of Enrollment
United States
|
12 participants
n=12 Participants
|
12 participants
n=12 Participants
|
24 participants
n=24 Participants
|
PRIMARY outcome
Timeframe: Approximately 60 minutes post surgical incisionMean vancomycin concentration in fat measured in ug/g at surgical closure
Outcome measures
| Measure |
Vancomycin 15mg/kg IV
n=72 fat
Will receive 15mg/kg based on actual body weight (maximum of 2g) of vancomycin via the systemic route at a rate of 15mg/kg as per hospital guidelines. Systemic IV vancomycin is given via a forearm vein, given over an infusion timed to finish immediately prior to surgery.
Vancomycin: Antibiotic
|
Vancomycin 500mg Intraosseous
n=72 fat
Will have the limb exsanguinated and an above knee tourniquet inflated to 300 mmHg. Immediately following tourniquet inflation, Group B will receive 500mg of vancomycin, via an EZ-IO intraosseous cannula. The vancomycin would be administered in 150ml of saline solution. The intraosseous cannula would be placed into the epiphysis of the proximal tibia. The tourniquet will be left inflated for 10 minutes following completion of the IORA injection then deflated.
Vancomycin: Antibiotic
|
|---|---|---|
|
Vancomycin Concentration in Fat
|
6.0 ug/g
Standard Deviation 0.85
|
40.5 ug/g
Standard Deviation 8.08
|
PRIMARY outcome
Timeframe: Approximately 60 minutes post surgical incisionMean vancomycin concentration in bone measured in ug/g at surgical closure
Outcome measures
| Measure |
Vancomycin 15mg/kg IV
n=48 bone
Will receive 15mg/kg based on actual body weight (maximum of 2g) of vancomycin via the systemic route at a rate of 15mg/kg as per hospital guidelines. Systemic IV vancomycin is given via a forearm vein, given over an infusion timed to finish immediately prior to surgery.
Vancomycin: Antibiotic
|
Vancomycin 500mg Intraosseous
n=48 bone
Will have the limb exsanguinated and an above knee tourniquet inflated to 300 mmHg. Immediately following tourniquet inflation, Group B will receive 500mg of vancomycin, via an EZ-IO intraosseous cannula. The vancomycin would be administered in 150ml of saline solution. The intraosseous cannula would be placed into the epiphysis of the proximal tibia. The tourniquet will be left inflated for 10 minutes following completion of the IORA injection then deflated.
Vancomycin: Antibiotic
|
|---|---|---|
|
Vancomycin Concentration in Bone
|
8.3 ug/g
Standard Deviation 0.77
|
26.9 ug/g
Standard Deviation 1.31
|
Adverse Events
Vancomycin 15mg/kg IV
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Vancomycin 500mg Intraosseous
Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place